References
- Humbert M, Chaouat A, Bertocchi M, et al. ItinerAIR-HTAP: A French National Prospective Registry of Pulmonary Arterial Hypertension. Abstract ATS 2004
- Zuber JP, Calmy A, Evison JM, et al. Pulmonary arterial hyper-tension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004;38:1178–85
- Speich R, Jenni R, Opravil M, et al. Primary pulmonary hypertension in HIV infection. Chest 1991;100:1268–71
- Recusani F, Di Matteo A, Gambarin F, et al. Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients. Aids 2003;17(Suppl 1):88–95
- Martinez Torres MA, Pavon Jimenez R, Corzo Delgado J, Pastor Torres L. [Pulmonary hypertension associated with human immunodeficiency virus infection: a review of 4 cases]. Rev Esp Cardiol 2002;55:673–7
- Speich R, Jenni R, Opravil M, Jaccard R. Regression of HIV-associated pulmonary arterial hypertension and longterm survival during antiretroviral therapy. Swiss Med Wkly 2001;131:663–5
- UNAIDS. AIDS Epidemic Update 2004. 2004. Ref Type: Serial (Book, Monograph)
- Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 2000;118:1133–41
- Kanmogne GD, Primeaux C, Grammas P. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 2005;333: 1107–15
- Caldwell RL, Gadipatti R, Lane KB, Shepherd VL. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. J Leukoc Biol 2006 Jan;79:192–201
- Opravil M, Pechere M, Speich R, et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 1997;155: 990–5
- Provencher S, Sitbon O, Humbert M, et al. G. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J 2006;27:589–95
- Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243–78
- Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation 1994;89:2722–7
- Sitbon O, Gressin V, Speich R, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;170:1212–7